Ara
Toplam kayıt 7, listelenen: 1-7
Thrombolytic Therapy in Pulmonary Embolism: Treating the Patient, Not Just the Disease
(Elsevier Science Inc, 2017)
Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study
(Springer, 2017)
The definition of non-valvular atrial fibrillation (NVAF) is controversial. We aimed to assess the impact of valvular heart disease on stroke prevention strategies in NVAF patients. The RAMSES study was a multicenter and ...
Right Heart Thrombi Treatment
(Elsevier Science Inc, 2017)
PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER study)
(Sage Publications Inc, 2017)
Introduction: Inappropriate use of oral anticoagulants (OACs) have not been well investigatedand, however, may be frequent in real-world practice in patients with nonvalvular atrial fibrillation (NVAF). This study was ...
Analysis of geographical variations in the epidemiology and management of non-valvular atrial fibrillation: results from the RAMSES registry
(Turkish Soc Cardiology, 2017)
Objective: This study aimed to determine the differences in terms of demographic characteristics and preferred stroke prevention strategies for patients with non-valvular atrial fibrillation living in seven geographical ...
Thrombolytic therapy in submassive pulmonary embolism
(Elsevier, 2017)
Kapak hastalığı dışı atriyum fibrilasyonu olan hastaların başvuru anındaki durumları ve verilen tedavilerin cinsiyete göre farklılıkları: RAMSES çalışması bulguları
(2017)
Amaç: Cinsiyet atriyum fibrilasyonu (AF) yönetimini etkileyen önemli bir özelliktir. Bu çalışmada, Türkiye'de AF'si olan hastalarda cinsiyet ile ilişkili farklar araştırıldı.Yöntemler: RAMSES (ReAl-life Multicenter Survey ...